Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR)Data Supports Further Clinical Development into Phase 3Conference call and webcast at 9 a.m. EDT, March ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE